Orange Book product · Generic (ANDA)
CANDESARTAN CILEXETIL
CANDESARTAN CILEXETIL
At a glance
Aug 21, 2023
Approved
Generic (ANDA)
Application
AB
TE code
None
Listed patents
Key dates
Approval
FDA approval date of this drug product.
Aug 21, 2023
2 yr 10 mo ago
Today
Pharmaceutical detail
Active ingredient
CANDESARTAN CILEXETIL
Strength
8MG
Dosage form
TABLET
Route
ORAL
TE code
AB
Application
ANDA 206233
Product number
001
Marketing status
RX
Reference listed drug (RLD)
No
Reference standard (RS)
No
Active-ingredient family
View full familyGeneric (ANDA) of CANDESARTAN CILEXETIL
- 1998ATACANDBrand (NDA)
NDA 020838 · ANI PHARMS
- 2018CANDESARTAN CILEXETILGeneric (ANDA)
ANDA 210302 · ALEMBIC
- 2017CANDESARTAN CILEXETILGeneric (ANDA)
ANDA 091390 · ZYDUS LIFESCIENCES
- 2017CANDESARTAN CILEXETILGeneric (ANDA)
ANDA 209119 · ALEMBIC
- 2016CANDESARTAN CILEXETILGeneric (ANDA)
ANDA 203813 · MACLEODS PHARMS LTD
- 2014CANDESARTAN CILEXETILGeneric (ANDA)
ANDA 202079 · APOTEX
- 2013CANDESARTAN CILEXETILGeneric (ANDA)
ANDA 078702 · MYLAN
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
